Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,154.00
Bid: 12,152.00
Ask: 12,156.00
Change: -16.00 (-0.13%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Goldman Sachs likes Big Yellow, Great Portland

Thu, 15th Dec 2022 09:25

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

Bank of America raises Rightmove price target to 625 (600) pence - 'buy'

----------

Credit Suisse cuts Diageo price target to 4,400 (4,550) pence - 'outperform'

----------

Credit Suisse raises Coca-Cola HBC target to 2,600 (2,550) pence - 'outperform'

----------

Investec raises Phoenix Group to 'buy'

----------

Investec cuts Aviva to 'hold' (buy)

----------

Deutsche Bank raises AstraZeneca price target to 13,000 (12,000) pence - 'buy'

----------

Bernstein raises Centrica price target to 128 (118) pence - 'outperform'

----------

Bernstein raises SSE price target to 2,175 (2,150) pence - 'outperform'

----------

Goldman Sachs raises Segro price target to 960 (950) pence - 'buy'

----------

Goldman Sachs raises British Land price target to 390 (350) pence - 'neutral'

----------

Goldman Sachs raises Land Securities to 'neutral' (sell) - price target 620 (500) pence

----------

LBBW cuts Vodafone price target to 120 (165) pence - 'buy'

----------

FTSE 250

----------

Bank of America cuts Baltic Classifieds price target to 150 (170) pence - 'neutral'

----------

Liberum cuts Currys price target to 135 (150) pence - 'buy'

----------

Liberum cuts Genus price target to 4,200 (5,470) pence - 'buy'

----------

Oddo BHF cuts Tui price target to 1.50 (1.70) EUR - 'underperform'

----------

JPMorgan raises Drax Group price target to 850 (825) pence - 'overweight'

----------

RBC cuts Drax Group price target to 1,030 (1,050) pence - 'outperform'

----------

HSBC cuts Moonpig price target to 210 (345) pence - 'buy'

----------

Barclays raises IntegraFin price target to 360 (350) pence - 'overweight'

----------

Goldman Sachs cuts Watches of Switzerland price target to 1,020 (1,045) pence - 'neutral'

----------

Goldman Sachs cuts Tritax Big Box price target to 160 (170) pence - 'buy'

----------

Goldman Sachs raises Derwent London price target to 2,910 (2,610) pence - 'buy'

----------

Goldman Sachs cuts Supermarket Income REIT price target to 97 (108) pence - 'neutral'

----------

Goldman Sachs raises Hammerson price target to 20 (17) pence - 'sell'

----------

Goldman Sachs raises Big Yellow to 'buy' (neutral) - price target 1,250 (1,130) pence

----------

Goldman Sachs raises Great Portland to 'buy' (neutral) - price target 570 (480) pence

----------

JPMorgan raises SSP price target to 350 (320) pence - 'overweight'

----------

JPMorgan raises Wizz Air price target to 3,400 (2,800) pence - 'overweight'

----------

JPMorgan raises easyJet price target to 320 (260) pence - 'underweight'

----------

JPMorgan raises Clarkson to 'overweight' (neutral) - price target 4,050 (3,380) pence

----------

SMALL CAP

----------

Barclays raises Victorian Plumbing to 'overweight' (equal weight) - price target 100 (75) pence

----------

JPMorgan raises Ryanair price target to 21 (18.20) EUR - 'overweight'

----------

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.